Hirschmann-Jax and colleagues were the first to observe that “side population” cancer stem-like cells isolated from cell lines and patients with neuroblastoma expressed high levels of ABCG2 and ABCG3 transporter genes as well as a greater capacity to expel cytotoxic drugs [44]. This evidence concerns the gene ABCG2 and cancer.